OncoTargets and Therapy
Volume 11, 2018 - Issue
Open access
78
Views
24
CrossRef citations to date
0
Altmetric
Original Research
miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway
Chuansheng Li1 Department of General Surgery, Shanxian Central Hospital, Heze, Shandong, China, [email protected]
, Jingwei Zhang1 Department of General Surgery, Shanxian Central Hospital, Heze, Shandong, China, [email protected]Correspondence[email protected]
, Zhongliang Ma2 Department of Breast Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
, Fan Zhang1 Department of General Surgery, Shanxian Central Hospital, Heze, Shandong, China, [email protected]
& Wenlong Yu1 Department of General Surgery, Shanxian Central Hospital, Heze, Shandong, China, [email protected]
Pages 4087-4095
|
Published online: 16 Jul 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.